Core Viewpoint - The company plans to acquire multiple health management centers through a share issuance, indicating a strategic move to expand its market presence and operational capacity [2][7]. Group 1: Acquisition Details - The company intends to purchase 84.00% of Hengyang Meinian Health Examination Center Co., Ltd., 81.00% of Ningde Meinian Health Management Co., Ltd., 75.00% of Yantai Meinian Health Examination Management Co., Ltd., and several other health management entities with varying ownership percentages [2][7]. - The acquisition includes minority stakes in several subsidiaries, such as 47.37% in Zhengzhou Meijian Health Management Co., Ltd. and 49.00% in Guangzhou Huadu District Meinian Health Management Co., Ltd. [2][7]. Group 2: Regulatory Process - On August 8, 2025, the company received a notice from the Shenzhen Stock Exchange acknowledging the acceptance of its application for the share issuance to purchase assets [3][8]. - The transaction is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, with the timeline for approval remaining uncertain [8].

Core Viewpoint - The company intends to acquire multiple health management and inspection centers through a share issuance, which has been accepted by the Shenzhen Stock Exchange for review [2][3][5]. Group 1: Acquisition Details - The company plans to purchase 84.00% of Hengyang Meinian Health Examination Center Co., Ltd., 81.00% of Ningde Meinian Health Management Co., Ltd., 75.00% of Yantai Meinian Health Examination Management Co., Ltd., and several other stakes in various health management companies [2][6]. - The acquisition includes minority stakes in several subsidiaries, such as 47.37% in Zhengzhou Meijian Health Management Co., Ltd. and 42.46% in Anhui Meixin Health Management Consulting Co., Ltd. [2][6]. Group 2: Regulatory Process - The company received a notification from the Shenzhen Stock Exchange on August 8, 2025, confirming the acceptance of its application for the share issuance to purchase assets [3][7]. - The transaction is subject to approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission, with timelines for approval being uncertain [3][7]. Group 3: Document Updates - The company has revised the draft report for the share issuance and acquisition, making minor updates without affecting the transaction plan [5][7].

Core Viewpoint - The AMAC Resident Services Index has shown significant growth, with a year-to-date increase of 7.13%, indicating a positive trend in the sector [1]. Group 1: Index Performance - The AMAC Resident Services Index rose by 1.62% to 16,699.22 points, with a trading volume of 8.395 billion yuan [1]. - Over the past month, the index has increased by 6.03%, and over the last three months, it has risen by 4.09% [1]. Group 2: Index Composition - The AMAC Resident Services Index is composed of 43 industry classification indices, including 16 categories (excluding manufacturing) and 27 subcategories within manufacturing [1]. - The top ten holdings in the AMAC Resident Services Index are: Aier Eye Hospital (38.18%), Meien Health (10.37%), Tongce Medical (9.11%), Kingmed Diagnostics (5.38%), International Medical (5.35%), Sanbo Brain Science (5.22%), Dean Diagnostics (5.07%), Innovation Medical (3.65%), Huaxia Eye Hospital (3.32%), and New Mileage (2.85%) [1]. Group 3: Market Distribution - The market distribution of the AMAC Resident Services Index shows that 83.84% of the holdings are from the Shenzhen Stock Exchange, while 16.16% are from the Shanghai Stock Exchange [1]. - The sample holdings of the AMAC Resident Services Index are entirely within the pharmaceutical and healthcare sector, indicating a focused investment strategy [2].

Core Viewpoint - The company intends to acquire a significant number of health management and inspection centers through a share issuance, which has been accepted by the Shenzhen Stock Exchange for review [2][3]. Group 1: Transaction Details - The company plans to purchase 84.00% of Hengyang Meinian Health Examination Center Co., Ltd., 81.00% of Ningde Meinian Health Management Co., Ltd., 75.00% of Yantai Meinian Health Examination Management Co., Ltd., and several other health management companies with varying ownership percentages [2]. - The ownership stakes in the targeted companies include 49.00% in Yantai Meinian Futen Health Examination Management Co., Ltd., 52.81% in Wuhan Meici Aoya Technology Management Co., Ltd., and 85.00% in Sanming Meinian Health Management Co., Ltd., among others [2]. Group 2: Regulatory Process - The Shenzhen Stock Exchange has acknowledged the receipt of the company's application for the share issuance to purchase assets, confirming that the application documents are complete [3]. - The transaction is subject to approval from the Shenzhen Stock Exchange and registration consent from the China Securities Regulatory Commission, indicating that the timeline for approval remains uncertain [3].

Group 1 - The company plans to acquire stakes in multiple health management and medical examination centers through a share issuance, including 84% in Hengyang Meinian Health Examination Center and 90% in Feicheng Meinian Health Management [2][3] - The company has received acceptance from the Shenzhen Stock Exchange for its application regarding the share issuance to purchase assets, as announced on August 8, 2025 [3] - The draft report for the asset purchase has undergone revisions to update the decision-making process and significant matters related to the transaction [3][4] Group 2 - The company updated its basic information according to the latest business license in the revised draft report [4] - Additional disclosures were made regarding the self-inspection of related parties buying and selling the company's stock [4]

北京市君泽君律师事务所 关于美年大健康产业控股股份有限公司 发行股份购买资产暨关联交易的 法 律 意 见 书 中国北京东城区金宝街 89 号金宝大厦 11 层 邮政编码:100005 11F, Jinbao Tower, 89 Jinbao Street, Dongcheng District, Beijing 10005, P.R.C. Tel: 861066523388 Fax: 861066523399 Http://www.junzejun.com | 释 | 义 2 | | --- | --- | | 正 | 文 11 | | 一、 | 本次交易的方案 11 | | 二、 | 本次交易相关方的主体资格 19 | | 三、 | 本次交易的批准和授权 47 | | 四、 | 本次交易的相关协议 51 | | 五、 | 本次交易的标的资产 52 | | 六、 | 本次交易涉及的关联交易及同业竞争 193 | | 七、 | 本次交易涉及的债权债务处理 195 | | 八、 | 本次交易的信息披露 196 | | 九、 | 本次交易的实质条件 196 | | 十、 | 相关当事人买卖证券行为的核查 202 | ...

粤开证券股份有限公司 关于 美年大健康产业控股股份有限公司 发行股份购买资产 暨关联交易 之 独立财务顾问报告 独立财务顾问 二〇二五年七月 | 目录… | | --- | | 独立财务顾问声明和承诺 . | | 一、独立财务顾问声明 . | | 二、独立财务顾问承诺 . | | 释 义 | | 重大事项提示 . | | 一、本次交易方案简要介绍 . | | 二、本次交易对上市公司的影响 | | 三、本次交易尚需履行的决策和审批程序 . | | 四、上市公司的实际控制人及其一致行动人对本次重组的原则性意见,以 | | 及上市公司实际控制人及其一致行动人、董事、监事、高级管理人员自本 | | 次重组预案或重组报告书披露之日起至实施完毕期间的股份减持计划 27 | | 五、本次交易对中小投资者权益保护的安排 | | 六、其他需要提醒投资者重点关注的事项 . | | 重大风险提示 . | | 一、与本次交易相关的风险 . | | 二、与标的资产相关的风险 . | | 三、其他风险 . | | 第一节 本次交易概况 ……………………………………………………………………………………………………………………………………… ...

股票代码：002044.SZ 股票简称：美年健康 上市地点：深圳证券交易所 美年大健康产业控股股份有限公司 发行股份购买资产暨关联交易 报告书（草案）（申报稿） | 项目 | 交易对方 | | | | --- | --- | --- | --- | | 发行股份购买资产 | 刘三宝、刘菊香、桂嘉男、吴雪彦、吕雪珍、吴星明、黄荣、程景森、 郑超、周涛、程绍举、刘景平、南通美富、上海宝思来、孙嘉凯、李 | | | | 暨关联交易 | 建国、海南丰誉、刘广、李红、张伟、绍兴柯美、许其玉、李冬秋、 | | | | | 甘泉、李京贞、郭美钦、冯霞芳、林峣、张燃、冯利松、杜海霞、张 | | | | | 乾、杜宏、研计公司、赵国荣、孟祥怀、卢秀梅等共 | 37 | 名交易对方 | 独立财务顾问 二〇二五年七月 美年大健康产业控股股份有限公司发行股份购买资产暨关联交易报告书（草案）（申报稿） 声明 本部分所述词语或简称与本报告书"释义"所述词语或简称具有相同含义。 一、上市公司声明 本公司及本公司全体董事、监事、高级管理人员保证为本次交易所提供的有 关信息的真实性、准确性、完整性，不存在任何虚假记载、误导性陈述或者重大 遗漏 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-057 美年大健康产业控股股份有限公司 关于发行股份购买资产暨关联交易申请文件 获得深圳证券交易所受理的公告 美年大健康产业控股股份有限公司 董 事 会 二〇二五年八月十二日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 美年大健康产业控股股份有限公司（以下简称"公司"）拟通过发行股份的方 式购买交易对方持有的衡阳美年健康体检中心有限公司 84.00%股权、宁德美年 大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00%股 权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管理 有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年健 康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 80.50%股权、山东美铭奥亚健康咨询有限公司 92.35%股权及公司控股子公司郑 州美健健康管理有限公司 47.37%少数 ...

证券代码：002044 证券简称：美年健康 公告编号：2025-058 关于发行股份购买资产暨关联交易报告书（草案）（申报稿） 修订说明的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 美年大健康产业控股股份有限公司（以下简称"公司"）拟通过发行股份的方 式购买交易对方持有的衡阳美年健康体检中心有限公司 84.00%股权、宁德美年 大健康管理有限公司 81.00%股权、烟台美年大健康体检管理有限公司 75.00%股 权、烟台美年福田健康体检管理有限公司 49.00%股权、武汉美慈奥亚科技管理 有限公司 52.81%股权、三明美年大健康管理有限公司 85.00%股权、肥城美年健 康管理有限公司 90.00%股权、德州美年大健康体检管理有限公司 84.00%股权、 连江美年大健康管理有限公司 82.00%股权、沂水美年大健康体检管理有限公司 80.50%股权、山东美铭奥亚健康咨询有限公司 92.35%股权及公司控股子公司郑 州美健健康管理有限公司 47.37%少数股权、广州花都区美年大健康管理有限公 司 49.00%少数股权、安徽美欣健康管理咨询有限公司 4 ...